Buprenorphine And Naloxone Tablet
Product Images NDC 71335-2981
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 71335-2981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Buprenorphine 02)
Image (Buprenorphine 03)
Label (Lbl713352981)
This text provides information about a sublingual tablet containing Buprenorphine & Naloxone Hydrochloride. The tablet includes Buprenorphine Hydrochloride, USP 8 mg, and Naloxone Hydrochloride Dihydrate, USP 2 mg. The recommended dosage is to scan the package insert QR code for full prescribing information. It is advised to dispense the medication guide to each patient and store the tablets at 20°C to 25°C (68°F to 77°F). The text also highlights the importance of preventing children from accidental ingestion and seeking emergency medical care if that occurs.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.